Clinical Trials
View the National Cancer Institute's "Understanding Cancer Clinical Trials" video. 
Read "On the Cutting Edge: Patients in Clinical Trials of New Drugs Must Weigh Risk vs Reward" from the November issue of New Jersey Monthly magazine.
Listen to the American Society of Clinical Oncologists' podcast entitled, "What are Clinical Trials."
Clinical research touches every person’s life on a regular basis. It plays an important role in moving medical science and improving the public’s health. According to the U.S. Census Bureau, more than half of all Americans are taking prescription medications at the present time. Most Americans report routinely using over-the-counter medications. All medicines, both prescription and over-the-counter, have gone through clinical testing, involving people who have volunteered to take part in a clinical trial, also known as a research study. All of today’s successful treatments for cancer are based on results of past clinical trials. Because of progress made through clinical trials, people treated for cancer are living longer.
As one of the National Cancer Institute’s designated cancer centers, The Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics or doctor’s offices. The Cancer Institute of New Jersey currently enrolls more than 1,000 patients in clinical trials or approximately 15% of all its new adult cancer patients and approximately 70% of all pediatric cancer patients on clinical trials. The Cancer Institute of New Jersey is committed to finding the latest and best treatment options for cancer patients through clinical trials.
For additional information about clinical trials at CINJ call 732-235-8675 or find a clinical trial at CINJ.
Recent News About Clinical Trials
CINJ Researchers Look at FDA Approved Drugs to Target Early-Stage Prostate Cancer
The FDA-approved drugs Celebrex® and Lipitor® used respectively for arthritis pain and lowering one’s cholesterol, are being tested by investigators at CINJ to see if they hold any promise in slowing or stopping the growth of prostate cancer when combined.
Study Examines Needs of Cancer Survivors When They No Longer Require Specialized Care
A research study sponsored by the National Cancer Institute, CINJ and the U.S. Department of Defense will look at how breast and prostate cancer survivors view their medical needs as they no longer need to be under the care of an oncologist and go back to their regular family doctor, internist or gynecologist for follow-up care.
Participants Sought for Jersey Girl Study Focusing on Pre-teen Girls in Relation to Breast Cancer Development
Can environmental and lifestyle factors predict whether young girls will be at risk for breast cancer in the future? That is what the Jersey Girl Study at CINJ aims to find out. The goal of the study is to understand how puberty is affected by environmental, hormonal and nutritional factors in nine- and ten-year-old girls, who live in the Garden State. Research studies have clearly identified puberty as a critical window in a woman’s development that has a major impact on her future risk of developing breast cancer.
|
